An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors market the substance there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering products of uncertain source.
Some professionals said the popularity for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of weight loss, positive testimonials and step-by-step guides for mixing or administering at residence.
Within moments of entering one group, a seller shared contact information, where the majority of transactions occur. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Product Details and Pricing
Inside these communities, posts display black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for the messaging service said it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially significant health risks”.
